HomeFBRX • NASDAQ
add
Forte Biosciences Inc
Previous close
$19.08
Day range
$17.80 - $19.45
Year range
$4.90 - $28.68
Market cap
232.50M USD
Avg Volume
115.11K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 18.38M | 113.04% |
Net income | -17.68M | -110.70% |
Net profit margin | — | — |
Earnings per share | -0.99 | 78.19% |
EBITDA | -18.37M | -113.09% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 93.41M | 470.89% |
Total assets | 97.09M | 441.01% |
Total liabilities | 12.99M | 51.42% |
Total equity | 84.10M | — |
Shares outstanding | 12.53M | — |
Price to book | 4.04 | — |
Return on assets | -44.86% | — |
Return on capital | -50.31% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -17.68M | -110.70% |
Cash from operations | -14.00M | -72.14% |
Cash from investing | -55.00K | — |
Cash from financing | 1.32M | 66,350.00% |
Net change in cash | -12.73M | -56.48% |
Free cash flow | -6.75M | -29.33% |
About
Founded
2007
Headquarters
Website
Employees
16